FDA warns on Warner-Lambert drug
Two recent setbacks for Rezulin, the diabetes treatment, povide ample room for competitors to grab market share from Warner-Lambert, manufacturer of the blockbuster drug, over the next few years. A
Two recent setbacks for Rezulin, the diabetes treatment, povide ample room for competitors to grab market share from Warner-Lambert, manufacturer of the blockbuster drug, over the next few years. A